Why no big-bang Indian pharma mergers?

Yes, this is an obvious question.   I've decided to ask it. The global pharmaceutical market is consolidating rapidly. Indian generics companies are struggling for scale and their new drug discovery ambitions have for the most part run up against a wall.  A good number have ageing promoters with the second (or third) generation having little … Continue reading Why no big-bang Indian pharma mergers?

Advertisement